...
首页> 外文期刊>Current gastroenterology reports. >Management of refractory ascites and hepatorenal syndrome.
【24h】

Management of refractory ascites and hepatorenal syndrome.

机译:难治性腹水和肝肾综合征的管理。

获取原文
获取原文并翻译 | 示例
           

摘要

One of the most common manifestations of the development of portal hypertension in the patient with cirrhosis is the appearance of ascites. Once ascites develops, the prognosis worsens and the patient becomes susceptible to complications such as bacterial peritonitis, hepatic hydrothorax, hyponatremia, and complications of diuretic therapy. As the liver disease progresses, the ascites becomes more difficult to treat and many patients develop renal failure. Most patients can be managed by diuretics which, when used correctly, will control the ascites. Spontaneous bacterial peritonitis can be treated effectively, but portends a worse prognosis. Once the ascites becomes refractory to diuretics, liver transplantation is the best option, although use of transjugular intrahepatic portosystemic shunts will control the ascites in many patients. Lastly, the development of hepatorenal syndrome indicates the patient's liver disease is advanced, and transplantation again is the best option. However, use of vasoconstrictors may improve renal function in some patients, helping in their management while they await a liver transplant.
机译:肝硬化患者门静脉高压症最常见的表现之一就是出现腹水。一旦出现腹水,预后就会恶化,患者容易发生并发症,例如细菌性腹膜炎,肝胸水,低钠血症和利尿剂治疗并发症。随着肝脏疾病的进展,腹水变得更加难以治疗,许多患者出现肾功能衰竭。多数患者可以使用利尿剂治疗,如果正确使用利尿剂,可以控制腹水。自发性细菌性腹膜炎可以有效治疗,但预后较差。一旦腹水对利尿剂无效,尽管使用经颈静脉肝内门体分流术将控制许多患者的腹水,但肝移植是最佳选择。最后,肝肾综合征的发展表明患者的肝脏疾病已经进展,再次移植是最佳选择。但是,使用血管收缩剂可能会改善某些患者的肾功能,帮助他们在等待肝移植时进行管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号